Nephrology

A study has shown that controlling blood pressure through active ultrafiltration rather than antihypertensive drugs significantly improves survival rates among CKD patients undergoing hemodialysis or hemodiafiltration.

A new therapy combining daratumumab and tocilizumab offers hope for kidney transplant patients battling late antibody-mediated rejection.

Intensive blood pressure control reduces cardiovascular risks in CKD patients but may increase adverse events, new real-world study shows.

Neutrophil-to-lymphocyte ratio predicts early mortality in older dialysis patients, offering insights for personalised treatment planning.

Alpha blockers increase fracture risk in female CKD patients treated for voiding dysfunction, emphasising the need for cautious prescribing.

A recent study highlights a significant risk for fractures in women with chronic kidney disease using alpha blockers for voiding dysfunction.

SGLT-2 inhibitors significantly lower mortality and adverse events in diabetic kidney transplant recipients, study reveals.

Robot-assisted kidney transplants offer outcomes comparable to open surgery for high-risk ABO-incompatible cases, study finds.